Avidity Partners Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-468,700
| Closed | -$42.7M | – | 86 |
|
|
2023
Q2 | $42.7M | Buy |
+468,700
| New | +$42.7M | 1.49% | 26 |
|
|
2022
Q4 | – | Sell |
-844,000
| Closed | -$57.6M | – | 86 |
|
|
2022
Q3 | $57.6M | Buy |
844,000
+629,000
| +293% | +$43M | 1.17% | 30 |
|
|
2022
Q2 | $9.72M | Buy |
215,000
+5,000
| +2% | +$226K | 0.22% | 50 |
|
|
2022
Q1 | $10.7M | Buy |
+210,000
| New | +$10.7M | 0.22% | 61 |
|
|
2021
Q1 | – | Sell |
-774,000
| Closed | -$44.3M | – | 96 |
|
|
2020
Q4 | $44.3M | Buy |
774,000
+150,700
| +24% | +$8.62M | 1.44% | 20 |
|
|
2020
Q3 | $18.8M | Buy |
+623,300
| New | +$18.8M | 0.87% | 36 |
|